Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DL14SU
|
|||
| Drug Name |
PF-07265803
|
|||
| Synonyms |
Emprumapimod
Click to Show/Hide
|
|||
| Drug Type |
Small molecule
|
|||
| Indication | Dilated cardiomyopathy [ICD-11: BC43.0; ICD-10: I42.0] | Phase 3 | [1] | |
| Company |
Pfizer
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Stress-activated protein kinase (p38) | Target Info | Antagonist | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03439514) A Phase 3, Multinational, Randomized, Placebo-controlled Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation (REALM-DCM). U.S.National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Pfizer | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.